+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Respiratory Drugs Market Research Reports

Interstitial Lung Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Interstitial Lung Disease - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 200 Pages
  • Global
From
Cough In Idiopathic Pulmonary Fibrosis (IPF) - Pipeline Insight,2025 - Product Thumbnail Image

Cough In Idiopathic Pulmonary Fibrosis (IPF) - Pipeline Insight,2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
Fungal Pneumonia - Pipeline Insight, 2025 - Product Thumbnail Image

Fungal Pneumonia - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Severe Asthma - Pipeline Insight, 2025 - Product Thumbnail Image

Severe Asthma - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 180 Pages
  • Global
From
Eosinophilic Asthma - Pipeline Insight, 2025 - Product Thumbnail Image

Eosinophilic Asthma - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Non-cystic Fibrosis Bronchiectasis - Pipeline Insight, 2025 - Product Thumbnail Image

Non-cystic Fibrosis Bronchiectasis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Alpha- Antitrypsin Deficiency - Pipeline Insight, 2025 - Product Thumbnail Image

Alpha- Antitrypsin Deficiency - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
TRELEGY ELLIPTA Market Size, Insight, and Forecast to 2032 - Product Thumbnail Image

TRELEGY ELLIPTA Market Size, Insight, and Forecast to 2032

  • Report
  • December 2024
  • 30 Pages
  • Global
From
CINQAIR Market Size, Insight, and Forecast to 2032 - Product Thumbnail Image

CINQAIR Market Size, Insight, and Forecast to 2032

  • Report
  • December 2024
  • 30 Pages
  • Global
From
SPIRIVA RESPIMAT Market Size, Insight, and Forecast to 2032 - Product Thumbnail Image

SPIRIVA RESPIMAT Market Size, Insight, and Forecast to 2032

  • Report
  • December 2024
  • 30 Pages
  • Global
From
ARNUITY ELLIPTA Market Size, Insight, and Forecast to 2032 - Product Thumbnail Image

ARNUITY ELLIPTA Market Size, Insight, and Forecast to 2032

  • Report
  • December 2024
  • 30 Pages
  • Global
From
FASENRA Market Size, Emerging Insight, and Forecast to 2032 - Product Thumbnail Image

FASENRA Market Size, Emerging Insight, and Forecast to 2032

  • Report
  • December 2024
  • 30 Pages
  • Global
From
From
Cystic fibrosis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Cystic fibrosis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Ofev (Nintedanib) - Drug Insight and Market Forecast - 2030 - Product Thumbnail Image

Ofev (Nintedanib) - Drug Insight and Market Forecast - 2030

  • Report
  • August 2020
  • 80 Pages
  • Global
From
From
Cystic Fibrosis Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Cystic Fibrosis Market Analysis & Forecast to 2024-2034

  • Report
  • March 2024
  • 200 Pages
  • Global
From
From
Loading Indicator

The Respiratory Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat respiratory diseases. These drugs are used to treat a variety of conditions, including asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Commonly prescribed respiratory drugs include bronchodilators, corticosteroids, and antibiotics. The Respiratory Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Companies in the market include GlaxoSmithKline, AstraZeneca, Merck & Co., Novartis, and Boehringer Ingelheim. These companies are constantly researching and developing new drugs to treat respiratory diseases, as well as improving existing treatments. Show Less Read more